The Tim-3/galectin-9 signaling pathway mediates T cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma [44]. The gene discussed is LGALS9; the disease is hepatocellular carcinoma.